the so-called "bad" cholesterol, was already well-controlled. Patients in the study were treated with Abbott Laboratories' Niaspan and Merck & Co. Inc.'s Zocor, a statin available generically as simvastatin. Shares of Abbott, for which Niaspan is nearly...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Feds say Abbott cholesterol drug doesn't prevent heart problems
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account